13 articles for K Sugimoto
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.

Astrazeneca
Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.

Amgen
Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.

Gifu Pharmaceutical University
Synthesis and biological evaluation of N-(2-fluorophenyl)-2ß-deoxyfuconojirimycin acetamide as a potent inhibitor fora-l-fucosidases.

University of Toyama
Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2).

University of Toyama
Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease.

Showa Pharmaceutical University
Sphingomyelin analogues as inhibitors of sphingomyelinase.

Taisho Pharmaceutical
Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L

TBA
Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.

University of Toyama
Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.

Kumamoto Health Science University
Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.

Taisho Pharmaceutical
Sila-Ibuprofen.

University of Bremen
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents.

Cyclacel